The Walden Group/Deal History

Deal History

175+ total transactions representing $2.5B+ in aggregate value — 20 tracked below spanning 2009–2025 · 2 industries

175+
Total Transactions
2
Industries
2009–2025
Years Active
Healthcare Products16
Sale of Hurricane Medical to Innovia Medical2025
Acquired by PE: Innovia Medical

Walden Group served as exclusive M&A adviser to Hurricane Medical, a leading manufacturer of single-use ophthalmic surgical products and instruments. Sale to Innovia Medical, a global medical device company backed by Inverness Graham Investments.

Sell SideSell Side Advisor
Sale of RICA Surgical Products to Mastel Precision Surgical Instruments2024
Strategic acquirer: Mastel Precision Surgical Instruments, Inc.

Walden Group represented RICA Surgical Products as investment banker and M&A adviser in its sale to Mastel Precision Surgical Instruments (Pacific Surgical family). RICA is a provider of innovative sterilization instrument trays and surgical instruments for medical and animal health markets.

Sell SideSell Side Advisor
Sale of Total Titanium (TTI) to Bausch & Lomb (NYSE:BLCO)2023
Strategic acquirer: Bausch & Lomb Incorporated

Walden guided TTI, a top-tier independently-owned manufacturer of ophthalmic surgical instruments and engineered precision components, in developing analyses and presentations for a highly synergistic transaction with major global eye health company B&L.

Sell SideSell Side Advisor
Merger of Katalyst Surgical with Carl Zeiss Meditec AG2022
Strategic acquirer: Carl Zeiss Meditec AG

Walden engaged more than 14 months prior to closing to prepare Katalyst Surgical, a leader in vitreoretinal instruments and ophthalmic surgical technologies, and organize a discrete corporate sale process to maximize valuation of its leading edge technology.

Sell SideSell Side Advisor
Sale of ASICO, LLC to Katena Products2021
Strategic acquirer: Katena Products (Now Corza Medical)

Walden represented ASICO, an industry leader for 35+ years providing high-quality ophthalmic surgical instruments, in its sale to Katena Products, a worldwide leader in specialty ophthalmic and optometric products. Walden guided the transaction through COVID market turbulence.

Sell SideSell Side Advisor
Majority Recapitalization of Riverpoint Medical, LLC with Arlington Capital Partners2020
Acquired by PE: Arlington Capital Partners

Walden served as Riverpoint's M&A advisor and helped navigate a process to find the best fit for Riverpoint and the Ferguson family. Riverpoint is a major developer of advanced bioabsorbable sutures, orthopedic implants, cordless surgical headlights, and brachytherapy devices.

RecapitalizationSell Side Advisor
Sale of Millennium Surgical Corp. to Avalign Technologies, Inc.2019
Acquired by PE: Avalign Technologies, Inc.

Walden represented Millennium Surgical Corp., a provider of branded surgical instruments to hospitals and surgery centers for orthopedics, neurosurgery, and ophthalmics, to Avalign Technologies (Arlington Capital portfolio company).

Sell SideSell Side Advisor
Sale of Endo Optiks LLC to Beaver-Visitec International (Roundtable Healthcare Partners)2018
Strategic acquirer: Beaver-Visitec International, Inc.

Walden represented Endo Optiks, a developer of minimally invasive ophthalmic diagnostic and surgical systems, in strategic transaction with major industry player to propagate technology across geographic markets.

Sell SideSell Side Advisor
Sale of VasSol, Inc. to Private Investor2017
Acquired by: Private Investor

Walden prepared VasSol, developer of the NOVA non-invasive stroke diagnostic system, and guided through a discrete offering process. NOVA system uses Quantitative Magnetic Resonance Angiograms (QMRAs) for objective blood flow measurement.

Sell SideSell Side Advisor
Sale of JoviPak Corporation to BSN Medical2017
Strategic acquirer: BSN Medical

Walden represented JoviPak, developer and pioneer of lymphedema compression products with variable pressure point technology. Walden prepared the founder and conducted process with synergistic operating companies and PE firms with woundcare and compression experience.

Sell SideSell Side Advisor
Sale of MicroSurgical Technology, Inc. to Halma plc (LSE:HLMA)2015
Strategic acquirer: Halma p.l.c.

Walden cultivated relationship with MicroSurgical Technology, a manufacturer of specialized ophthalmic surgical devices (Malyugin ring pupil expander), and assisted Halma in structuring and completing the transaction.

Sell SideSell Side Advisor
Sale of Visiometrics, S.L. to Halma plc (LSE:HLMA)2015
Strategic acquirer: Halma p.l.c.

Walden identified Barcelona-based Visiometrics as strategic fit for Halma, cultivated the relationship with principals, and assisted in structuring the transaction. Visiometrics manufactures vision quality instruments to measure early onset of cataracts.

Sell SideSell Side Advisor
Sale of IOP Ophthalmics (Arxa5 Corporation) to Katena Holdings/Cortec Group2014
Strategic acquirer: Katena Holdings/Cortec Group

Walden identified IOP Ophthalmics as strategic add-on acquisition fit for Katena/Cortec Group. IOP is a provider of amniotic membranes and ophthalmic surgical technologies.

Sell SideSell Side Advisor
Sale of The Surgical Lighting Division of Lumitex, Inc. to Cura Surgical, Inc.2013
Strategic acquirer: Cura Surgical, Inc.

Walden represented Cura Surgical in fitted, strategic transaction. Lumitex's advanced cool, shadowless lighting applications adhere to retractors and provide enhanced illumination for open surgical sites.

Sell SideSell Side Advisor
Sale of The PedAlign Foot Orthotics Business to Orthotics Holdings Inc./Frazier Healthcare2012
Acquired by PE: Orthotics Holdings Inc.

Walden represented a foot orthotics company with international operations, involving cross-border dynamics. PedAlign offered high-margin custom orthotic solutions through podiatry and professional channels.

Sell SideSell Side Advisor
Sale of Katena Instruments to Cortec Group2009
Acquired by PE: Cortec Group

Walden represented Katena's founder in sale to PE-backed Cortec Group. Katena is a leading provider of surgical instruments for ophthalmic surgery.

Sell SideSell Side Advisor
Healthcare Services4
Sale of Argentum Medical, LLC to Shore Capital Partners2020
Acquired by PE: Shore Capital Partners

Walden prepared Argentum Medical, an advanced woundcare company with Silverlon antimicrobial dressing technology, and conducted a private process to engage operating companies and PE sponsors. Core platform uses uniquely-designed silver-plated nylon matrix technology.

Sell SideSell Side Advisor
Sale of Attentus Medical Sales to Medical Specialty Distributors, LLC2019
Acquired by PE: Medical Specialty Distributors, LLC

Walden secured multiple offers and evaluated all aspects for Attentus Medical Sales, a provider of specialized products and consulting services to compounding, specialty, and infusion pharmacies. Buyer is portfolio company of New Mountain Capital.

Sell SideSell Side Advisor
Sale of Life Systems, Inc. to STERIS Incorporated (NYSE:STE)2016
Strategic acquirer: STERIS Incorporated

Walden represented Life Systems, a leading endoscopic instrument repair and maintenance company, to STERIS for expanded midwest penetration and endoscope repair technical expertise.

Sell SideSell Side Advisor
Sale of Total Repair Express (TRE) to STERIS Corporation (NYSE:STE)2014
Strategic acquirer: STERIS Corporation

Walden represented Total Repair Express, a national provider of comprehensive surgical instrument repair services, difficult-to-source custom parts, and sophisticated instrument tracking systems, to STERIS.

Sell SideSell Side Advisor